If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
420.00    -5.00 (-1.19%)
Bid:
410.00
Ask:
420.00
Spread: 10.00 (2.439%)
Market Cap: £169.24m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

Directorate change

7 Apr 2026 14:30

RNS Number : 5045Z
Videndum PLC
07 April 2026
 

 

7 April 2026

 

Videndum plc

 

Board Changes

 

Videndum plc ("Videndum" or "the Company") announces that Martin Cooke will cease to be an independent non-executive director of the Company with effect from 30 April 2026. Martin was appointed at the end of July 2025 to support the Board with the refinancing of the business that successfully completed on 30 March 2026. At the same time, Graham Oldroyd will cease to be Deputy Chairman and will revert to his former role as Chair of the Finance Committee and an independent non-executive director.

 

Commenting on the Board changes, Stephen Harris, Videndum's Chairman said: "On behalf of the Board and our stakeholders I would like to express thanks to Martin who has provided invaluable support to enable Videndum to refinance its business and to secure its future in the most challenging of circumstances. Given that we now have a stable platform for growth the Board will be focusing on business opportunities and returning to a more common governance structure. Graham will revert to his previous role as an independent non-executive director and Chair of the Finance Committee. We are actively pursuing the recruitment of a permanent Chief Executive Officer and will update shareholders on progress with this search as soon as we have something able to."

 

For more information please contact:

Videndum plc

Stephen Harris, Chairman Email: IR-enquiries@videndum.com

Brian Morgan, Group Chief Financial Officer

FTI Consulting

Richard Mountain

Telephone: 020 3272 1340

 

A snapshot of Videndum plc

 

Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market.

 

Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, robotic camera systems, prompters, LED lighting, mobile power, bags, backgrounds, audio capture, and noise reduction equipment.

 

We employ around 1,200 people across the world in 9 different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

 

More information can be found at: https://videndum.com/

 

LEI number: 2138007H5DQ4X8YOCF14

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAIRMTTMTJMBTF
Date   Source Headline
30th Apr 20257:00 amRNS2024 Full Year Results
22nd Apr 20257:00 amRNSNotice of FY24 Results; Debt financing update
31st Mar 20257:00 amRNSMarch Covenant Test Waived
19th Mar 20257:00 amRNSDirectorate Change
11th Mar 20253:45 pmRNSHolding(s) in Company
5th Mar 20254:00 pmRNSHolding(s) in Company
21st Feb 20257:00 amRNSTrading Update
8th Jan 20257:00 amRNSHolding(s) in Company
7th Jan 202510:00 amRNSDirector/PDMR Shareholding
19th Dec 20241:38 pmRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSPre-Close Trading Update
11th Dec 20247:00 amRNSPre-Close Trading Update - Change of Date
22nd Nov 20242:15 pmRNSHolding(s) in Company
22nd Nov 20241:00 pmRNSNotice of Pre-Close Trading Update
20th Nov 20247:00 amRNSBlock listing Interim Review
6th Nov 20248:50 amRNSTransaction in Own Shares and cancellation
6th Nov 20248:34 amRNSShare buyback and cancellation programme
1st Nov 20249:58 amRNSTotal Voting Rights
28th Oct 20247:00 amRNSDirectorate Changes
10th Oct 20243:45 pmRNSHolding(s) in Company
8th Oct 20243:05 pmRNSHolding(s) in Company
4th Oct 20247:00 amRNSHolding(s) in Company
1st Oct 20243:40 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSHolding(s) in Company
27th Sep 20243:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNS2024 Interim Results
2nd Sep 20249:23 amRNSTotal Voting Rights
1st Aug 202412:30 pmRNSTotal Voting Rights
11th Jul 20247:00 amRNS2024 Half Year Post-close Statement
19th Jun 202411:05 amRNSResult of AGM
19th Jun 20247:00 amRNSNon-Executive Director appointment
13th Jun 202411:00 amRNSDirector/PDMR Shareholding
20th May 202411:45 amRNSBlock listing Interim Review
16th May 20245:00 pmRNSDirector/PDMR Shareholding
10th May 202410:26 amRNSChange in Director's Details
8th May 20244:15 pmRNSAnnual Report & Accounts and Notice of 2024 AGM
7th May 202411:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSDirectorate Change
23rd Apr 20247:10 amRNSDirectorate Change
23rd Apr 20247:00 amRNS2023 Full Year Results
27th Mar 20242:03 pmRNSUpdate on timing of 2023 Full Year Results
13th Mar 20242:15 pmRNSDelay to 2023 Full Year Results Date
7th Mar 20241:30 pmRNSHolding(s) in Company
23rd Feb 20244:38 pmRNSHolding(s) in Company
9th Feb 202410:46 amRNSHolding(s) in Company
26th Jan 202411:38 amRNSHolding(s) in Company
11th Jan 20244:47 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20232:01 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.